Case against axillary lymphadenectomy for most patients with infiltrating breast cancer

J Surg Oncol. 1997 Sep;66(1):7-10. doi: 10.1002/(sici)1096-9098(199709)66:1<7::aid-jso3>3.0.co;2-8.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Axilla
  • Breast Neoplasms / economics
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery*
  • Carcinoma, Ductal, Breast / economics
  • Carcinoma, Ductal, Breast / secondary
  • Carcinoma, Ductal, Breast / surgery*
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Lymph Node Excision* / economics
  • Lymphatic Metastasis
  • Neoplasm Invasiveness
  • Randomized Controlled Trials as Topic
  • Survivors